Gary Hunninghake is Professor of Medicine at Brigham and Women's Hospital. OpenAlex indexes 221 publications with 15,053 citations (h-index 61); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Gary Hunninghake, MD, is Professor of Medicine at Brigham and Women's Hospital. The public record shows 221 publications with 15,053 citations (h-index 61), centered on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) Research, Medical Imaging and Pathology Studies. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 4 companies, 5 NIH-funded awards (2006–2026).
- Most recent indexed publication: 2026 · American journal of respiratory and critical care medicine
- Top research focus: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 125.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
Sponsor: Duke University
Industry payments
Updated 14 Oct 2026
4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim International GmbHProgram year20252 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20252 payments
- United Therapeutics CorporationProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
76.9%Kinase inhibitor53.1%Ofev100%Part D≥15 patientsPyridone23.8%Pirfenidone100%Part D<11 patientsMetabolism & gastrointestinal
23.1%Corticosteroid23.1%Prednisone100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
5 NIH research awards on record, funded 2006–2026 per NIH RePORTER. The latest:
- Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities
Brigham and Women'S Hospital
FY2026$1,582,806R01HL135142 - Clinical Genetics and Screening for Pulmonary Fibrosis
Brigham and Women'S Hospital
FY2026$1,257,790R01HL130974 - Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities
Brigham and Women'S Hospital
FY2025$1,542,983R01HL135142
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Association of a Polygenic Risk Score with Diagnosis and Outcomes in Idiopathic Pulmonary Fibrosis.
American journal of respiratory and critical care medicine
Article2026 - Abatacept for the treatment of myositis-associated interstitial lung disease.
Rheumatology (Oxford, England)
Clinical Trial2025 - Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.
American journal of respiratory and critical care medicine
Guideline2025
Most-cited works
by citation count (OpenAlex)- 01Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary DiseaseArticle1,295 citations2012
- 02Serum Vitamin D Levels and Markers of Severity of Childhood Asthma in Costa RicaArticle639 citations2009
- 03Lung Volumes and Emphysema in Smokers with Interstitial Lung AbnormalitiesArticle617 citations2011
- 04
- 05Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung InjuryArticle569 citations2012
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/gary-hunninghake-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Gary-Hunninghake
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/SchillerLab/status/1647890842353278977
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- MPH
Harvard School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗ - Board certification
Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physiciandirectory.brighamandwomens.org ↗ - Board certification
Pulmonary Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗ - Board certification
Critical Care Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Media & interviews
press, podcasts and appearances- Guest
"Approach to the Evaluation and Management of Interstitial Lung Abnormalities" episode, Out of the Blue: An AJRCCM Podcast (American Thoracic Society), with Anna Podolanczuk, hosted by Mohleen Kang
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →transistor.fm ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
Marc Sabatine, MD
Brigham and Women's Hospital
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital